These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 13512043)
21. [Therapy of diseases of the blood and of the hemopoietic system]. RATKOCZY N Orv Hetil; 1961 Feb; 102():385-93. PubMed ID: 13739745 [No Abstract] [Full Text] [Related]
22. [On chemotherapy of hemoblastoses and malignant tumors]. LINKE A; FREUDENBERGER B Probl Symp Aktuell Ther; 1960; 3():38-134. PubMed ID: 13762454 [No Abstract] [Full Text] [Related]
23. [Cytostatic therapy of malignant tumors in urology]. Peter S Krankenpfl J; 1987 Dec; 25(12):16-9. PubMed ID: 3431085 [No Abstract] [Full Text] [Related]
24. [Chemotherapy of malignant adrenal gland tumors]. Zielinski CC; Schernthaner G Acta Med Austriaca; 1988; 15(4):120-2. PubMed ID: 3213381 [TBL] [Abstract][Full Text] [Related]
25. [Cytostatic drugs--mechanism of action and guidelines for clinical use]. Sauer H Fortschr Med; 1989 Oct; 107(29):604-11. PubMed ID: 2680840 [TBL] [Abstract][Full Text] [Related]
26. [Side-effects of cytostatic agents]. Mayr AC; Nagel GA; Dick HJ; Obrecht JP Schweiz Med Wochenschr; 1973 Sep; 103(36):1252-5. PubMed ID: 4270669 [No Abstract] [Full Text] [Related]
27. [Cytostatic drugs in the treatment of proliferative & neoplastic processes of the hemopoietic system]. MIEDZIANOWSKI A Pol Tyg Lek (Wars); 1958 Mar; 13(9):326-32. PubMed ID: 13553909 [No Abstract] [Full Text] [Related]
29. Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Countouriotis A; Moore TB; Sakamoto KM Stem Cells; 2002; 20(3):215-29. PubMed ID: 12004080 [TBL] [Abstract][Full Text] [Related]
33. [Inhibition of hemopoiesis due to cytostatic therapy and its treatment (author's transl)]. Klener P; Donner L; Smotlachová I Cas Lek Cesk; 1977 Feb; 116(4):117-9. PubMed ID: 844069 [No Abstract] [Full Text] [Related]
34. [Quantitative immunoglobulin determination as a monitoring technic in hematologic diseases under cytostatic therapy]. Knolle J; Wörz R; Meyer zum Büschenfelde Verh Dtsch Ges Inn Med; 1969; 75():492-7. PubMed ID: 4099583 [No Abstract] [Full Text] [Related]
36. [Lessons with general medicine can draw from the treatment of hemoblastoses]. BASERGA A Sang; 1956; 27(7):623-32. PubMed ID: 13390784 [No Abstract] [Full Text] [Related]
38. Tumors of skin. IX. Local cytostatic therapy of cutaneous and mucosal premalignant and malignant lesions. Klein E N Y State J Med; 1968 Apr; 68(7):886-9. PubMed ID: 5238573 [No Abstract] [Full Text] [Related]
39. [Status of testing cytostatic drugs in the therapy of malignant tumors]. Mattern J; Wayss K; Volm M Dtsch Med Wochenschr; 1986 Apr; 111(17):676-8. PubMed ID: 3516620 [No Abstract] [Full Text] [Related]
40. Treatment of malignant haematological diseases: from maximally tolerated to minimally required? de Pauw BE Curr Opin Oncol; 2006 Nov; 18(6):648-51. PubMed ID: 16988589 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]